Investors & Owners
The current shareholder structure at Marinomed is as follows: the founders and management team of Marinomed are the core shareholders with around 27% of total shares. Long-term investor Acropora, which has been invested since the foundation in 2006, holds some 14% of shares, while approximately 62% are in free float.
Marinomed is supported by several public funding bodies, including:
Österreichische Forschungsförderungs GmbH (FFG)
Austria Wirtschaftsservice GmbH (AWS)
Stephanie Kniep, Dipl.-Ök.
Head of Investor Relations